Business · 29/06/2006
FDA to Discuss Use of Bayesian Statistics in Medical Device Clinical Trials
The Food and Drug Administration (FDA) is hosting a public meeting to discuss its draft guidance on the use of Bayesian statistical methods in medical device clinical trials, which aims to provide recommendations for the design and analysis of these trials.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →